Deletion analysis of the imprinting center region in patients with Angelman syndrome and Prader-Willi syndrome by real-time quantitative PCR

Genetic Testing

Volumn 8, Issue 4, 2004, Pages 387-394

  Raca, Gordana ^a   Buiting, Karin ^b   Das, Soma ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FAMILIAL DISEASE; GENE DELETION; GENETIC ANALYSIS; GENOME IMPRINTING; HAPPY PUPPET SYNDROME; HUMAN; NUCLEOTIDE SEQUENCE; PRADER WILLI SYNDROME; REAL TIME POLYMERASE CHAIN REACTION; RECURRENT DISEASE; RISK ASSESSMENT;

ANGELMAN SYNDROME; DIAGNOSIS, DIFFERENTIAL; DNA; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; GENOMIC IMPRINTING; HUMANS; POLYMERASE CHAIN REACTION; PRADER-WILLI SYNDROME; SENSITIVITY AND SPECIFICITY;

EID: 11444249801     PISSN: 10906576     EISSN: None     Source Type: Journal    
DOI: 10.1089/gte.2004.8.387     Document Type: Article

References (45)

1. AARSKOG N.K., and VEDELER C.A. (2000). Real-time quantitative polymerase chain reaction. A new method that detects both the peripheral myelin protein 22 duplication in Charcot-Marie-Tooth type 1A disease and the peripheral myelin protein 22 deletion in hereditary neuropathy with liability to pressure palsies. Hum. Genet. 107, 494-498.
2. ARADHYA, S., WOFFENDIN, H., JAKINS, T., et al. (2001). A recurrent deletion in the ubiquitously expressed NEMO (IKK-gamma) gene accounts for the vast majority of incontinentia pigmenti mutations. Hum. Mol. Genet. 10, 2171-2179.
3. ASHG/ACMG TEST AND TECHNOLOGY TRANSFER COMMITTEE. (1996). Diagnostic testing for Prader-Willi and Angleman syndromes: Report of the ASHG/ACMG Test and Technology Transfer Committee. Am. J. Hum. Genet. 58, 1085-1088.
4. BUITING, K., DITTRICH, B. GROSS, S., et al (1998). Sporadic imprinting defects in Prader-Willi syndrome and Angelman syndrome: Implications for imprint-switch models, genetic counseling, and prenatal diagnosis. Am. J. Hum. Genet. 63, 170-180.
5. BUITING, K., GROSS, S., LICH, C., et al. (2003). Epimutations in Prader-Willi and Angelman syndromes: a molecular study of 136 patients with an imprinting defect. Am. J. Hum. Genet. 72, 571-577.
6. BUITING, K., LICH, C., COTTRELL, S., et al. (1999). A 5-kb imprinting center deletion in a family with Angelman syndrome reduces the shortest region of deletion overlap to 880 bp. Hum. Genet. 105, 665-666.
7. BUITING, K., SAITOH, S., GROSS, S., et al. (1995). Inherited microdeletions in the Angelman and Prader-Willi syndromes define an imprinting center on human chromosome 15. Nat. Genet. 9, 395-400.
8. BURGER, J., BUITING, K., DITTRICH, B., et al. (1997). Different mechanisms and recurrence risks of imprinting defects in Angelman syndrome. Am. J. Hum. Genet. 61, 88-93.
9. CASILLI, F., DI ROCCO, Z.C., GAD, S., et al. (2002). Rapid detection of novel BRCA1 rearrangements in high-risk breast-ovarian cancer families using multiplex PCR of short fluorescent fragments. Hum. Mutat. 20, 218-226.
10. CUSCO, I., BARCELO, M.J., BAIGET, M., et al. (2002). Implementation of SMA carrier testing in genetic laboratories: comparison of two methods for quantifying the SMN1 gene. Hum. Mutat. 20, 452-459.
11. DESILVA, D., and REISER, A. (1998). Rapid genotyping and quantification on the LightCycler with Hybridization probes. Biochemica 2, 12-15.
12. EL-MAARRI, O., SUITING, K., PEERY, E.G., et al. (2001). Maternal methylation imprints on human chromosome 15 are established during or after fertilization. Nat. Genet. 27, 341-344.
13. FAUGERE, V., TUFFERY-GIRAUD, S., HAMEL, C., et al. (2003). Identification of three novel OA1 gene mutations identified in three families misdiagnosed with congenital nystagmus and carrier status determination by real-time quantitative PCR. BMC Genet. 4 www.biomedcentral.com/1471-2156/4/1 (Last accessed October 9, 2004).
14. FELDKOTTER, M., SCHWARZER, V., WIRTH, R., et al. (2002). Quantitative analyses of SMN1 and SMN2 based on real-time LightCycler PCR: Fast and highly reliable carrier testing and prediction of severity of spinal muscular atrophy. Am. J. Hum. Genet. 70, 358-368.
15. GINZINGER, DG. (2002). Gene quantification using real-time quantitative PCR: An emerging technology hits the mainstream. Exp. Hematol. 30, 503-512.
16. GUNDRY, C.N., BERNARD, P.S., HERRMANN, M.G., et al. (1999). Rapid F508del and F508C assay using fluorescent hybridization probes. Genet. Test. 3, 365-370.
17. HE, L., CHINNERY, P.F., DURHAM, S.E., BLAKELY, E.L., et al. (2002). Detection and quantification of mitochondrial DNA deletions in individual cells by real-time PCR. Nucleic Acids Res. 30, e68.
18. HEDRICH, K., KANN, M., and LANTHALER, A.J. (2001). The importance of gene dosage studies: mutational analysis of the parkin gene in early-onset parkinsonism. Hum. Mol. Genet. 10, 1649-1656.
19. HEID, C.A., STEVENS, J., LIVAK, K.J., and WILLIAMS, P.M. (1996). Real time quantitative PCR. Genome Res. 6, 986-994.
20. HIRATSUKA, M., NARAHARA, K., KISHIKAWA, Y., et al. (2002). A simultaneous LightCycler detection assay for five genetic polymorphisms influencing drug sensitivity. Clin. Biochem. 1, 35-40.
21. HORSTHEMKE, B., DITTRICH, B., and BUITING, K. (1997). Imprinting mutations on human chromosome 15. Hum. Mutat. 10, 329-337.
22. JONCOURT, F., NEUHAUS, B., JOSTARNDT-FOEGEN, K. (2004). Rapid identification of Female Carriers of DMD/BMD by Quantitative Real-Time PCR. Hum. Mutat. 23, 385-391.
23. KARIYAZONO, H., OHNO, T., IHARA, K., et al. (2001). Rapid detection of the 22q 11.2 deletion with quantitative real-time PCR. Mol. Cell. Probes. 15, 71-73.
24. KLEIN, D. (2002). Quantification using real-time PCR technology: Applications and limitations. Trends Mol. Med. 8, 257-260.
25. KUBOTA, T., DAS, S., CHRISTIAN, S.L., et al. (1997). Methylation-specific PCR simplifies imprinting analysis. Nat. Genet. 16, 16-17.
26. LIE. Y.S., PETROPOULOS, C.J. (1998). Advances in quantitative PCR technology: 5′ nuclease assays. Curr. Opin. Biotechnol. 9, 43-48.
27. LOHMANN, S., LEHMAN, L. (2000). Fast and flexible single nucleotide polymorphism (SNP) detection with the LightCycler system. Biochemica 4, 23-28.
28. LORENTZOS, P., KAISER, T., KENNERSON, M.L., et al. (2003). A rapid and definitive test for Charcot-Marie-Tooth 1A and hereditary neuropathy with liability to pressure palsies using multiplexed real-time PCR. Genet. Test. 7, 135-138.
29. MANGASSER-STEPHAN, K., TAG, C., REISER, A., et al. (1999). Rapid genotyping of hemochromatosis gene mutations on the LightCycler with fluorescent hybridization probes. Clin. Chem. 45, 1875-1878.
30. MORGAN, N.V., TIPPING, A.J., JOENJE, H., et al. (1999). High frequency of large intragenic deletions in the Fanconi anemia group A gene. Am. J. Hum. Genet. 65, 1330-1341.
31. NICHOLLS, R.D., and KNEPPER, J.L. (2001). Genome organization, function, and imprinting in Prader-Willi and Angelman syndromes. Annu. Rev. Genomics Hum. Genet. 2, 153-175.
32. NIESTERS. H.G. (2002). Clinical virology in real time. J. Clin. Virol. 25, 3-12.
33. OHTA, T., GRAY, T.A., ROGAN, P.K., et al. (1999). Imprinting-mutation mechanisms in Prader-Willi syndrome. Am. J. Hum. Genet. 64, 397-413.
34. PETRIJ-BOSCH, A., PEELEN, T., VAN VLIET, M., et al. (1997). BRCA1 genomic deletions are major founder mutations in Dutch breast cancer patients. Nat. Genet. 17, 341-345.
35. POULSEN, L., HORN, N., HEILSTRUP, H., et al. (2002a). X-linked recessive Menkes disease: Identification of partial gene deletions in affected males. Clin. Genet. 62, 449-457.
36. POULSEN, L., HORN, N., and MOLLER, L.B. (2002b). X-linked recessive Menkes disease: Carrier detection in the case of a partial gene deletion. Clin. Genet. 62, 440-448.
37. RASSMUSSEN, R.P., and MORRISON, T.B. (1998). Quantitative PCR by continuous fluorescence monitoring of a double strand DA specific binding dye. Biochemica. 1, 8-11.
38. RUIZ-PONTE, C., LOIDI, L., VEGA, A., et al. (2000). Rapid real-time fluorescent PCR gene dosage test for the diagnosis of DNA duplications and deletions. Clin. Chem. 46, 1574-1582.
39. SAITOH, S., BUITING, K., CASSIDY, S.B. et al. (1997). Clinical spectrum and molecular diagnosis of Angelman and Prader-Willi syndrome patients with an imprinting mutation. Am. J. Med. Genet. 68, 195-206.
40. SAITOH, S., BUITING, K., ROGAN, P.K., et al. (1996). Minimal definition of the imprinting center and fixation of chromosome 15q11-q13 epigenotype by imprinting mutations. Proc. Natl. Acad. Sci. U.S.A. 93, 7811-7815.
41. SCHOLLEN, E., SMEETS, E., DEFLEM, E., et al. (2003). Gross rearrangements in the MECP2 gene in three patients with Rett syndrome: Implications for routine diagnosis of Rett syndrome. Hum. Mutat. 22, 116-120.
42. SCHOUTEN, J.P., MCELGUNN, C.J., WAAIJER, R., et al. (2002). Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification. Nucleic Acids Res. 30, e57.
43. THIEL, C.T., KRAUS, C., RAUCH, A., et al. (2003). A new quantitative PCR multiplex assay for rapid analysis of chromosome 17p11.2-12 duplications and deletions. Eur. J. Hum. Genet. 11, 170-178.
44. WIJNEN, J., VAN DER KLIFT, H., VASEN, H., et al. (1998). MSH2 genomic deletions are a frequent cause of HNPCC. Nat. Genet. 20, 326-328.
45. WITTWER, C.T., and HERRMANN, M.G., MOSS, A.A., et al. (1997). Continuous fluorescence monitoring of rapid cycle DNA amplification. Biotechniques 22, 130-131, 134-138.